Adverse renal effects of anaplastic lymphoma kinase inhibitors and the response to alectinib of an ALK+ lung cancer patient with renal dysfunction

Figures & data

Figure 1 Timeline of the patient’s renal function.

Abbreviation: eGFR, estimate glomerular filtration rate.

Figure 2 Chest X-rays obtained (A) before and (B) after alectinib therapy.

Figure 3 Chest computed tomography scans obtained (A) before and (B) after alectinib therapy.